Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rational Design of (Oxadiazol-2-yl) Thiazolidin-4-one Derivatives for Parkinson's Disease: Insights from MD Simulations and Quantum Studies.
Journal: CNS & neurological disorders drug targets
Published: August 11, 2025
Unravelling the Proteinopathic Engagement of α-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.
Journal: Neurochemical research
Published: March 16, 2025
Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson's disease with in vitro evaluation.
Journal: Scientific reports
Published: November 07, 2024
System biology-based assessment of the molecular mechanism of IMPHY000797 in Parkinson's disease: a network pharmacology and in-silico evaluation.
Journal: Scientific reports
Published: July 23, 2024
Is SIRT3 and Mitochondria a Reliable Target for Parkinson's Disease and Aging? A Narrative Review.
Journal: Molecular neurobiology
Published: March 13, 2024
In-silico, Synthesis, Characterization, and In-vitro Studies on Benzylidene-based 2-chloroquinolin Derivatives as Free Radical Scavengers in Parkinson's Disease.
Journal: Drug research
Published: February 12, 2024
New stability chiral RP-HPLC method for degradation products determination in midodrine hydrochloride.
Journal: Drug development and industrial pharmacy
Published: April 05, 2021
Plant Derived Immunomodulators; A Critical Review.
Journal: Advanced pharmaceutical bulletin
Published: March 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026